Hit-to-Lead studies: the discovery of potent adamantane amide P2X7 receptor antagonists.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2003-11-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2003.08.034PMID 14592505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor.

  2003cited by this paper
• Novel P2X7 receptor antagonists.

  2003cited by this paper
• Molecular physiology of P2X receptors.

  2002cited by this paper
• Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response

  2002cited by this paper
• On the Role of the P2X7 Receptor in the Immune System

  2001cited by this paper
• The medicinal chemistry of the P2 receptor family.

  2001cited by this paper
• Overview of P2 receptors: Possible functions in immune cells

  2001cited by this paper
• Potent P2X7 receptor antagonists: Tyrosyl derivatives synthesized using a sequential parallel synthetic approach

  2001cited by this paper
• Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.

  1998cited by this paper
• The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytes

  1997cited by this paper
• Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.

  1994cited by this paper

• Radioligands Targeting the Purinergic P2X Receptors

  2025cites this paper
• Unlocking therapeutic potential: the role of adamantane in drug discovery

  2024cites this paper
• Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics

  2024cites this paper
• Structural Characterization, Spectroscopic Profile, Molecular Docking, ADMET Properties, Molecular Dynamics Simulation Studies, and Molecular Mechanics Generalized Born Surface Area Analysis of 5-(Adamantan-1-yl)-4-butyl-2,4-dihydro-3H-1,2,4-triazole-3-thione as a Potential COX Inhibitor

  2024cites this paper
• P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats

  2024cites this paper
• An Investigation on Linker Modifications of Cyanoguanidine‐Based P2X7 Receptor Antagonists

  2024cites this paper
• Synthetic molecules as P2X7 receptor antagonists: A medicinal chemistry update focusing the therapy of inflammatory diseases.

  2023cites this paper
• Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.

  2023cites this paper
• Design and synthesis of adamantane-1-carbonyl thiourea derivatives as potent and selective inhibitors of h-P2X4 and h-P2X7 receptors: An Emerging therapeutic tool for treatment of inflammation and neurological disorders.

  2022cites this paper
• Development and clinical translation of P2X7 receptor antagonists: A potential therapeutic target in coronary artery disease?

  2022cites this paper
• Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis.

  2022cites this paper
• A comparison of homogeneous and heterogeneous copper catalyzed arylation of amines

  2022cites this paper
• Mono- and Diamination of 4,6-Dichloropyrimidine, 2,6-Dichloropyrazine and 1,3-Dichloroisoquinoline with Adamantane-Containing Amines †

  2021cites this paper
• Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery

  2021cites this paper
• Radioligands targeting purinergic P2X7 receptor.

  2020cites this paper
• Quantum chemical, experimental, theoretical spectral (FT-IR and NMR) studies and molecular docking investigation of 4,8,9,10-tetraaryl-1,3-diazaadamantan-6-ones

  2019cites this paper
• Challenges and Opportunities in Central Nervous System Drug Discovery

  2019cites this paper
• New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies.

  2019cites this paper
• Arylation of Adamantanamines: X. Palladium- and Copper-Catalyzed Heteroarylation of Adamantane-Containing Amines with Bromopyridines

  2019cites this paper
• The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases.

  2018cites this paper
• Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay

  2018cites this paper
• Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation

  2018cites this paper
• The Palladium-Catalyzed Heteroarylation of Adamantylalkyl Amines with Dihalogenopyridines: Scope and Limitations

  2017cites this paper
• From UTP to AR-C118925, the discovery of a potent non nucleotide antagonist of the P2Y2 receptor.

  2017cites this paper
• New polycyclic small molecules as ion channel modulators

  2017cites this paper
• Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.

  2017cites this paper
• Discovery and pharmacological evaluation of a novel series of adamantyl cyanoguanidines as P2X7 receptor antagonists.

  2017cites this paper
• Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X7 Receptor Antagonist.

  2017cites this paper
• Sandwiches of N-doped diamondoids and benzene via lone pair–cation and cation–pi interaction: a DFT study

  2017cites this paper
• Challenges and Opportunities for the Application of Boron Clusters in Drug Design.

  2016cites this paper
• CuI-catalyzed N,N’-diarylation of diamines of adamantane series

  2016cites this paper
• Electronic structure, hydrogen bonding and spectroscopic profile of a new 1,2,4-triazole-5(4H)-thione derivative: A combined experimental and theoretical (DFT) analysis

  2016cites this paper
• Synthesis, crystal structure, anti-HIV, and antiproliferative activity of new oxadiazole and thiazole analogs

  2016cites this paper
• Catalyst-free amination of 2-fluoropyridine and 2-fluoro-5-halopyridines with adamantane amines

  2015cites this paper
• Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study

  2015cites this paper
• Synthesis, Antimicrobial and Hypoglycemic Activities of Novel N-(1-Adamantyl)carbothioamide Derivatives

  2015cites this paper
• An Improved Method for P2X7R Antagonist Screening

  2015cites this paper
• Purinergic P2X receptors: structural models and analysis of ligand-target interaction.

  2015cites this paper
• Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor Antagonists.

  2015cites this paper
• Nanoparticle-encapsulated P2X₇ receptor antagonist in a pH-sensitive polymer as a potential local drug delivery system to acidic inflammatory environments.

  2015cites this paper
• Rapid Vortex Fluidics: Continuous Flow Synthesis of Amides and Local Anesthetic Lidocaine.

  2015cites this paper
• Time-Gated Luminescence Detection for High-Throughput Screening of Protein Interaction and Inhibitions

  2015cites this paper
• Spectroscopic investigation (FT-IR and FT-Raman), vibrational assignments, HOMO-LUMO analysis and molecular docking study of 2-(Adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole.

  2015cites this paper
• Mechanisms of Resistance to New Generation Anti-TB Drugs

  2015cites this paper
• Unusual Sulfuric Acid-Induced Thiol Oxidation on Dehydrative Cyclization of Potassium N′-(1-Adamantylcarbonyl)Dithiocarbazate at Room Temperature

  2014cites this paper
• Synthesis, antimicrobial, and anti-inflammatory activity, of novel S-substituted and N-substituted 5-(1-adamantyl)-1,2,4-triazole-3-thiols

  2014cites this paper
• Development of 1,8-naphthalimides as clathrin inhibitors.

  2014cites this paper
• Antimicrobial and Hypoglycemic Activities of Novel N-Mannich Bases Derived from 5-(1-Adamantyl)-4-substituted-1,2,4-triazoline-3-thiones

  2014cites this paper
• FT-IR, FT-Raman, molecular structure, first order hyperpolarizability, HOMO and LUMO analysis, MEP and NBO analysis of 3-(adamantan-1-yl)-4-(prop-2-en-1-yl)-1H-1,2,4-triazole-5(4H)-thione, a potential bioactive agent.

  2014cites this paper
• Vibrational spectroscopic studies (FT-IR, FT-Raman) and quantum chemical calculations on 5-(Adamantan-1-yl)-3-[(4-fluoroanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione, a potential chemotherapeutic agent.

  2014cites this paper
• Structural and spectroscopic characterization of a novel potential anti-inflammatory agent 3-(adamantan-1-yl)-4-ethyl-1H-1,2,4-triazole-5(4H)thione by first principle calculations.

  2014cites this paper
• The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activity.

  2014cites this paper
• Neuraminidase-producing oral mitis group streptococci potentially contribute to influenza viral infection and reduction in antiviral efficacy of zanamivir

  2014cites this paper
• Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy.

  2014cites this paper
• Analyzing compound and project progress through multi-objective-based compound quality assessment.

  2013cites this paper
• Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists.

  2013cites this paper
• Novel IKKβ inhibitors discovery based on the co-crystal structure by using binding-conformation-based and ligand-based method.

  2013cites this paper
• Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.

  2013cites this paper
• Cellular fluorescent high-throughput screening assays of the ATP-gated P2X7 receptor

  2013cites this paper
• The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

  2013cites this paper
• Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567

  2013cites this paper
• Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.

  2012cites this paper
• P 2 X receptor-mediated ATP purinergic signaling in health and disease

  2012cites this paper
• Rola sygnalizacji purynergicznej i cytokin w indukcji procesów zapalnych w udarze niedokrwiennym mózgu

  2012cites this paper
• Disruption of clathrin-mediated endocytosis through small molecule inhibition of dynamin and clathrin

  2012cites this paper
• Molecules to selectively target receptors for treatment of pain and neurogenic inflammation.

  2012cites this paper
• P2X receptor-mediated ATP purinergic signaling in health and disease

  2012cites this paper
• The role of phosphatidylinositol 3-kinase in P2X7R gated signalling in T lymphocytes

  2012cites this paper
• Rola ektopuryn w procesie od zapalenia do demielinizacji – perspektywy powstania nowych metod leczenia stwardnienia rozsianego

  2011cites this paper
• Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.

  2011cites this paper
• The many faces of the adamantyl group in drug design.

  2011cites this paper
• Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.

  2011cites this paper
• [The role of ecto-purines in inflammation leading to demyelination - new means for therapies against multiple sclerosis].

  2011cites this paper
• Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.

  2010cites this paper
• Identification and characterization of a novel variant of the human P2X7 receptor resulting in gain of function

  2010cites this paper
• This information is current as Potentially Involved in Joint Diseases Cytokine-Independent Mechanism Cathepsins from Macrophages Is a Receptor-Mediated Release of 7 P 2 X

  2010cites this paper
• P2X7 Receptor-Mediated Release of Cathepsins from Macrophages Is a Cytokine-Independent Mechanism Potentially Involved in Joint Diseases

  2010cites this paper
• Palladium-catalyzed amination of isomeric dihalobenzenes with 1- and 2-aminoadamantanes

  2010cites this paper
• Synthesis, Antimicrobial, and Anti-inflammatory Activities of Novel 5-(1-Adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles and Related Derivatives

  2010cites this paper
• Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain.

  2009cites this paper
• Discovery of small molecule human C5a receptor antagonists.

  2009cites this paper
• Purinergic P2X(7) receptor antagonists: Chemistry and fundamentals of biological screening.

  2009cites this paper
• Antagonists of the P2X(7) receptor. From lead identification to drug development.

  2009cites this paper
• Discovery of small molecule human FPR1 receptor antagonists.

  2009cites this paper
• Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.

  2009cites this paper
• Purinergic receptor expression in neuronal, bladder smooth muscle and urothelial cells : characterization and inhibition by low molecular weight antagonists

  2009cites this paper
• Band gap tuning in nanodiamonds: first principle computational studies

  2009cites this paper
• The P2X7 receptor as a therapeutic target

  2008cites this paper
• Cubyl amides: novel P2X7 receptor antagonists.

  2008cites this paper
• P2X7, inflammation and gastrointestinal disease

  2008cites this paper
• Selective P2X7 receptor antagonists for chronic inflammation and pain

  2008cites this paper
• Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation

  2008cites this paper
• Potential Therapeutic Targets for ATP-Gated P2X Receptor Ion Channels

  2008cites this paper
• Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states

  2007cites this paper
• Interleukin-18: a pro-inflammatory cytokine that plays an important role in acute pancreatitis

  2007cites this paper
• The role of the purinergic P2X7 receptor in inflammation

  2007cites this paper
• Diamondoids as Molecular Building Blocks for Nanotechnology

  2007cites this paper
• Liaisons dangereuses: P2X(7) and the inflammasome.

  2007cites this paper
• Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists.

  2007cites this paper
• The role of the purinergic P 2 X 7 receptor in inflammation

  2007cites this paper